Despite intense interest in expanding chemical space, libraries containing hundreds-of-millions to billions of diverse molecules have remained inaccessible. Here we investigate structure-based docking of 170 million make-on-demand compounds from 130 well-characterized reactions. The resulting library is diverse, representing over 10.7 million scaffolds that are otherwise unavailable. For each compound in the library, docking against AmpC β-lactamase (AmpC) and the D 4 dopamine receptor were simulated. From the top-ranking molecules, 44 and 549 compounds were synthesized and tested for interactions with AmpC and the D 4 dopamine receptor, respectively. We found a phenolate inhibitor of AmpC, which revealed a group of inhibitors without known precedent. This molecule was optimized to 77 nM, which places it among the most potent non-covalent AmpC inhibitors known. Crystal structures of this and other AmpC inhibitors confirmed the docking predictions. Against the D 4 dopamine receptor, hit rates fell almost monotonically with docking score, and a hit-rate versus score curve predicted that the library contained 453,000 ligands for the D 4 dopamine receptor. Of 81 new chemotypes discovered, 30 showed submicromolar activity, including a 180-pM subtype-selective agonist of the D 4 dopamine receptor.
In a highly cited footnote, Bohacek and colleagues suggested that there are over 10 63 drug-like molecules 1 . This is too many to even enumerate, and other estimates of drug-like chemical space have been proposed 2-4 . What is clear is that the number of possible drug-like molecules is many orders of magnitude higher than the number that exists in early discovery libraries, and that this number grows exponentially with molecular size 3 . Because most optimized chemical probes and drug candidates resemble the initial discovery hit 5 , there is much interest in expanding the number of molecules and chemotypes that can be explored in early screening.
Expanding chemical space
An early effort to enlarge chemical libraries focused on the enumeration of side chains from central scaffolds. Although such combinatorial libraries can be very large, efforts to produce and test them often suffered from problems with compound synthesis, assay artefacts 6 and a lack of diversity. More recently, a related strategy using DNAencoded libraries 7 has overcome many of these deficits 8 . Still, most DNA-encoded libraries are limited to several reaction types or core scaffolds 9 , reducing diversity.
In principle, structure-based docking can screen virtual libraries of great size and diversity, selecting only the best-fitting molecules for synthesis and testing. These advantages are balanced by serious deficits: docking cannot calculate the affinity of a compound accurately 10 and the technique has many false-positive hits. Accordingly, docking of readily available molecules is crucial. For virtual molecules, such accessibility has been problematic. Worse still, a large library screen could exacerbate latent docking problems, giving rise to new falsepositive hits. Thus, although docking screens of several million molecules have found potent ligands for multiple targets [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , docking much larger virtual libraries has remained largely speculative.
To overcome the problem of compound availability in a make-ondemand library, we focused on molecules from 130 well-characterized reactions using 70,000 building blocks from Enamine (Fig. 1) . The resulting reaction products are often functionally congesteddisplaying multiple groups from a compact scaffold-with substantial three-dimensionality; less than 3% are commercially available from another source. The addition of new reactions and building blocks has steadily grown the library (Fig. 1a ). At the time of publication, there are over 350 million make-on-demand molecules in ZINC (http://zinc15. docking.org) in the lead-like range 23 . More than 1.6 billion readily synthesizable molecules have been enumerated, and the dockable library should soon grow beyond 1 billion molecules ( Fig. 1b) . Meanwhile, diversity is retained: a new scaffold is added for approximately every 20 new compounds (Fig. 1c) . As a consequence of its great size and diversity, a library of this size is almost entirely virtual.
Even if the make-on-demand molecules are readily accessible, a combination of inaccurate scores and a vast chemical space could overwhelm the true active compounds with docking decoys. Accordingly, we simulated how hit rates would vary as the library grew from tensof-thousands to hundreds-of-millions of molecules. First, we docked tens-to-hundreds of known ligands mixed with thousands of property-matched decoys 24 (Extended Data Fig. 1a, b ). From the resulting rank distributions, we simulated the effect of varying the ligandto-decoy ratio in a growing library. Performance was judged by the number of ligands in the top 1,000 ranked molecules for any library size, a stringent criterion. When ligands were enriched in the smaller libraries, performance typically improved with library size (Extended Article reSeArcH Data Fig. 1c ). Conversely, when docking performed poorly in small benchmarks, performance often deteriorated with library size.
Second, we investigated ligand enrichment against the full makeon-demand library. We counted known binding compounds as well as their close analogues in the library as ligands; the rest of the library was considered to be decoys (Methods). For targets with well-formed binding sites, known ligands and ligand analogues were found among the top docking hits, even in libraries of more than 170 million molecules (Extended Data Fig. 1d and Supplementary Table 1 ).
Docking 99 million molecules against AmpC
Encouraged by these simulations, we turned to prospective prediction of new compounds. We targeted two unrelated proteins: the enzyme AmpC and the D 4 dopamine (D 4 ) receptor. Against AmpC, we docked the make-on-demand lead-like library, which was-at the time-composed of 99 million molecules. Each compound was fit in the enzyme active site with an average of 4,054 orientations, and for each orientation 280 conformations were sampled. Each configuration was scored for energetic fit, using the physics-based DOCK3.7 scoring function. The top-ranked 1 million molecules were clustered by scaffold 25 and by topological similarity, reducing redundancy. Molecules were excluded that resembled known AmpC inhibitors from ChEMBL 26 (ECFP4 Tanimoto coefficient (Tc) > 0.45) or that resembled any molecule in the 3.5 million in-stock library (ECFP4 Tc > 0.5). Therefore, we sought molecules that were newly generated and matched to the enzyme.
Fifty-one top-ranking molecules-each a different scaffold-were selected for testing, of which 44 (86%) were successfully synthesized ( Supplementary Table 9 and Supplementary Data 11, 12). Five compounds measurably inhibited AmpC, with inhibitory constant (K i ) values ranging from 1.3 to 400 μM (Extended Data Figs. 2, 3), constituting an 11% hit rate. All five compounds were selective competitive inhibitors that did not aggregate, nor did they inhibit counter-screening enzymes such as trypsin and chymotrypsin (Supplementary  Tables 2, 3) . Notably, the compound ZINC339204163 at 1.3 μM engages the crucial oxyanion hole of AmpC with a phenolate. Not only is 339204163 the most potent reversible AmpC inhibitor found in any screen of which we are aware, but also its phenolate is a warhead that is rarely-if ever-known to interact with β-lactamases, and is one with few precedents among inhibitors of other amidases and proteases 27 . To optimize the five initial hits, we chose 90 well-scoring analogues from within the make-on-demand library (Methods). Over half were active on testing, improving the affinity of each of the 5 hits by 3-to 29-fold (Extended Data Fig. 2 and Supplementary Table 2 ). This included the compound ZINC549719643 (77 nM), an analogue of the phenolate 339204163, which is among the most potent non-covalent AmpC inhibitors of which we are aware. The ability to optimize affinity by finding analogues within the library attests to its depth of coverage for many chemotypes.
Crystal structures of three of the new ligand families, and of 549719643 at 77 nM, were determined to a resolution that ranged from 1.50 to 1.91 Å. Unambiguous electron density maps confirmed their fidelity to the docking predictions, with root mean square deviation (r.m.s.d.) values that varied from 0.98 to 1.52 Å (Fig. 2 , Extended Data Table 1 and Extended Data Fig. 4 ). The r.m.s.d. increases to 1.98 Å for ZINC275579920; however, this largely reflects a rotation of the terminal ring, which makes no polar interactions with the enzyme in either conformation. For the central core of 275579920, the r.m.s.d. is 1.20 Å and all five hydrogen bonds predicted by docking are found in the crystal structure ( Fig. 2b ). Such polar interactions corresponded well between docked and crystallographic poses in all four structures, including that of the phenolate of 549719643, which forms the three docking-predicted hydrogen bonds with the oxyanion hole of AmpC ( Fig. 2e ). 
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Docking 138 million molecules against the D 4 receptor
The prospective screen against the D 4 receptor had two goals. The first was to see whether we could discover new receptor chemotypes, as with most docking investigations. A second goal was to investigate something that remains largely unexplored in molecular docking: how success varies with docking rank. Accordingly, we tested 549 make-ondemand molecules drawn from not only high-ranking molecules, but also from mid-and low-ranked ones ( Fig. 3a ).
Seeking new chemotypes 28, 29 , 138 million library molecules were docked against the structure of the receptor 14 . About 70 trillion complexes were sampled in the orthosteric site, requiring 43,563 core hours or about 1.2 calendar days on 1,500 cores. Again, the ranked library was clustered by topology and by scaffold 25 , reducing redundancy. To increase novelty, molecules found in the 3.5 million in-stock library, or that resembled the approximately 28,000 dopaminergic, serotonergic or adrenergic ligands in ChEMBL (https://www.ebi.ac.uk/chembl/) (Tc ≥ 0.35 by ECFP4 fingerprints), were excluded. Of the 589 molecules selected, 549 (93%) were successfully synthesized ( Supplementary  Table 10 and Supplementary Data 11, 13). From the top 1,000 ranking clusters, 124 molecules were selected by visual inspection for favourable and diverse interactions with the D 4 site and for lack of internal strain 30 ; another 444 were selected automatically, by docking score alone, across the rank-ordered list (19 were in both lists). At 10 μM, 122 of the 549 molecules displaced more than 50% 3 H-N-methylspiperone-specific D 4 receptor binding ( Fig. 3a ). Dose-response curves for 81 compounds revealed K i values that ranged from 18.4 nM to 8.3 μM ( Fig. 3b , Extended Data Table 2 and Supplementary Table 4 ).
Many of the highly ranked molecules were functionally congested, and often docked to interact with residues that are rarely simultaneously engaged ( Fig. 3c and Extended Data Fig. 5 ). Most filled the pocket defined by residues in helices 5 and 6, such as S196 5.42 , F410 6.51 and F411 6.52 , and ion-paired with D115 3.32 , both common interactions among dopaminergic ligands ( Fig. 3c , superscripts use Ballesteros-Weinstein and GPCRdb nomenclature 31, 32 ). Less common among previously known ligands, but frequently observed here, was engagement of the D 4 receptor selectivity pocket, defined by F91 2.61 and L111 3.28 , which distinguishes this subtype from the D 2 and D 3 dopamine receptors ( Fig. 3c ). This may explain the 30-to 500-fold subtype selectivity of many of the hits (Extended Data Table 2 ). Finally, some compounds docked to further hydrogen-bond with backbone atoms in extracellular loop 2 ( Fig. 3c ), which is thought to influence signalling bias 33 .
In functional assays, several of the high-ranking molecules were potent. For instance, ZINC621433143 appeared to be a full agonist at 2.3 nM (see below), ZINC465129598 and ZINC270269326 were full agonists at 24 nM and 17 nM, respectively, whereas ZINC464771011 was a partial agonist at 10 nM ( Fig. 3d and Extended Data Table 2 ). Two antagonists were also found: ZINC413570733 (half-maximum inhibitory concentration (IC 50 ) = 5.9 μM) and ZINC130532671 (IC 50 = 10.8 μM) (Extended Data Table 2 and Extended Data Fig. 5 ). All six compounds lacked detectable activity against the D 2 or D 3 dopamine receptor subtypes (Extended Data Table 2 ). Meanwhile, ZINC615622500 had no detectable G i activity, but was a β-arrestinbiased agonist at 3 μM (Extended Data Table 2 and Extended Data Fig. 5 ).
Notably, the potent agonist 21433143 was tested as a diastereomeric mixture. Several of its diastereomers, each independently docked, also scored well-an example is ZINC621433144, which differs from 21433143 by adopting the (3R, 4S) rather than the (3S, 4S) stereoisomer around the tetrahydropyrrole; the two stereoisomers superpose well onto their docked poses on the D 4 receptor ( Fig. 3c ). Accordingly, the four diastereomers were independently synthesized and tested. Compound 621433144 is a full agonist at 180 pM, with 2,500-fold subtype selectivity, making it one of the most potent, selective full agonists characterized for the D 4 receptor. Compound 621433144 was also functionally selective, with a 17-fold bias towards G i signalling versus β-arrestin recruitment, compared to the characteristic agonist quinpirole ( Fig. 3e ). Two of the other diastereomers, ZINC361131264 and ZINC361131265, had G i biases of 26-and 11-fold, respectively, and the third (21433143) had a β-arrestin bias of 7-fold (Extended Data Table 2); here stereoisomerization at a single centre flips the bias of a potent agonist.
The make-on-demand library will soon exceed one billion lead-like molecules (Fig. 1b) , and it is tempting to dock only cluster representatives, rather than every single molecule. Indeed, doing so reduced docking time by 22-fold. Unfortunately, the best cluster representative for a protein is unknowable without docking all cluster members. We found that only docking a single cluster representative, chosen by multiple criteria (Methods), substantially reduced the docking scores, especially for the highest-ranked molecules ( Fig. 3f and Extended Data Fig. 6a ). This had a devastating effect on experimentally active scaffold families. For instance, the 47 confirmed active compounds among the top 3,000 ranked molecules were replaced with different cluster representatives, and these fell in rank by an average of 1,121,443; only 2 of the original active scaffolds remained ( Supplementary Table 7 ). Similar effects were observed for β-lactamase (Extended Data Fig. 6b and Supplementary  Table 8 ). Screening the entire library was essential for the discovery of the compounds that we report here.
Docking hit rates vary regularly with score
A longstanding question in docking is how well rank predicts binding likelihood. In most docking screens, only tens of molecules are tested, and then only from among the top ranks. With the great expansion of the library, it seemed interesting to sample also from lower ranks, with enough molecules to be statistically meaningful. Accordingly, we modelled potential 'hit-rate' curves as a function of docking score. Using distributions of prior probabilities from Bayesian statistics, we developed ranges of docking scores over which we should test molecules to experimentally define the curve (Fig. 4 ). From these simulations, the 549 make-on-demand molecules were spread among 12 scoring bins covering the highest-ranking (−75 to −63 kcal mol −1 ), mid-ranking (-61 to −46 kcal mol −1 ) and low-ranking scores, for which most molecules had unconvincing receptor interactions (−43 to −35 kcal mol −1 ). Typically, 35 to 40 molecules were tested per bin, with more in the highest scoring bins to maximize the number of active compounds found. Overall, 444 molecules were picked automatically, whereas 124 were picked by visual inspection (as described above). All molecules were tested in vitro using the same protocol. Notably, hit rates fell almost monotonically with score, after a plateau defined by the highest-ranking molecules. In this plateau region, hit rates ranged from 22 to 26%, but below scores of -65 kcal mol −1 hit rates decreased steadily to 12% for a docking score of -54 kcal mol −1 and at scores of -43 kcal mol −1 , the hit rate reached zero, where it remained for the next two (worse) scoring bins. We fit a response curve to these observations, with a top hit rate at 24%, a bottom hit rate at 0%, a mid-point at −54 kcal mol −1 and a mid-point hit-rate slope of −1.7% per kcal mol −1 . The regularity of this curve suggests that, at least for the D 4 receptor, ligand activity is well-predicted by docking score, notwithstanding a high false-positive rate and an inevitable false-negative rate.
From this curve we can model the total number of compounds that are active against the D 4 receptor in the library. Assuming that all molecules in a scoring range have the same hit rates, we can multiply the total number of library molecules in any such range by the observed hit rate in that range and sum ( Fig. 4 ). Among the library of 138 million molecules, we calculated there to be over 453,000 D 4 receptor active molecules, in over 72,600 scaffolds, with estimated K i values of 10 μM or better (Fig. 4a, c) . The number of active compounds drops to 158,000 at a more stringent 1 μM cut-off ( Fig. 4b, d ). Admittedly, these predictions have uncertainties, with 95% confidence intervals ranging from 188,000 to 1,035,000 active molecules and from 38,000 to 129,000 active scaffolds. Still, in some ways the estimates are conservative-for instance, we assume a 0% rate of compound discovery below a docking score of −40 kcal mol −1 (Fig. 4a, b ). Had we assumed a higher random hit rate, the number of discoverable compounds would have increased, as most of the library scored lower than −35 kcal mol −1 (Fig. 4 ). Finally, we note that this unusually large set of 549 confirmed active and inactive compounds, all with docking poses, may be a useful benchmark for the field (see https://figshare.com/articles/D4_bench-mark_mols_mol2/7367288/2 and Supplementary Table 4 ).
Human versus machine
We wondered whether molecules prioritized by docking and human visual evaluation would perform better than those prioritized Article reSeArcH by docking alone. From among the top 1,000 ranked molecules, we selected 124 that-on inspection-had favourable interactions, and deprioritized those with strained internal energies 30 . Another 114 high-ranking molecules were selected by docking score alone, from the same ranks. Unexpectedly, the hit rates were about the same at around 24% (Extended Data Fig. 7a ). However, the molecules prioritized by human inspection typically had better affinities: 44% of these were submicromolar, which was true of only 27% of those prioritized by docking score alone. Correspondingly, a disproportionate number of the most potent agonists, such as 621433144 (180 pM) and 464771011 (14 nM), were selected by human prioritization (Extended Data Fig. 7b, c) .
The docking results presented here can be compared to those from previous high-throughput screening and docking studies. For AmpC, the direct docking active 339204163 is over 20 times more potent than previously described non-covalent inhibitors [34] [35] [36] , and its optimized analogue 549719643 is among the most potent non-covalent AmpC inhibitors of which we are aware. This reflects in part the simple absence of phenolates from the much smaller libraries that were previously screened. Similarly, the low-and mid-nanomolar agonists 465129598, 270269326 and 464771011 are tenfold more potent than any D 4 receptor screening hits of which we are aware, even from studies biased towards dopaminergic chemotypes 37 , and are also more selective. Similarly, the compound 621433144 at 180 pM is among the most potent selective agonists reported for this target [38] [39] [40] . Comparing this study to a recent docking screen of 600,000 in-stock compounds against the D 4 receptor 14 , the initial lead from the smaller library was an agonist that was effective at 260 nM, and even after three rounds of optimization resulted only in an agonist that is effective at 4 nM. As was true for the phenolate compounds that interacted with AmpC, in this case no compound that is topologically similar to 621433144 was found in the smaller, in-stock library. It is the great expansion of the make-on-demand library, both in compounds and chemotypes, that has enabled the discovery of new ligands.
Certain caveats merit mentioning. The variation of the hit rate with docking score-although sigmoidal-was not fully monotonic, with variability among the sets of top-ranking molecules tested. Also, the estimate of active compounds is valid only for the D 4 receptor and has wide error margins (Fig. 4) . Whereas molecules were docked as pure stereoisomers and diastereomers, they were often tested as stereochemical mixtures. Furthermore, long-standing challenges with regards to the sampling and scoring of compounds in molecular docking screens remain 41 . Whereas the hit rate versus docking score curve (Fig. 4) supports the ability to prioritize active compounds, our raw docking scores remain off-set from true binding energies, and we cannot confidently rank-order molecules for activity. Finally, docking undoubtedly continues to suffer from false-negative hits.
These caveats should not obscure our principal observations. First, docking rank predicts the likelihood that a molecule will bind to the D 4 receptor (Fig. 4 ). This suggests that docking methods [42] [43] [44] [45] [46] [47] [48] [49] , at least for well-formed binding sites, can efficiently prioritize new molecules from a large chemical space. Second, the discovery of novel and potent chemotypes for both targets suggests that the ultra-large libraries contain molecules that are better suited to a given receptor structure than can be found within the smaller in-stock libraries, and that docking can recognize them. Third, the well-behaved hit rate versus score curve ( Fig. 4 ) allows one to predict the total number of expected active compounds for a target within a library, including those unrelated to known ligands. Integrating under this curve predicts that there are a notable 453,000 D 4 receptor ligands in over 72,000 scaffold families in the make-on-demand library. As daunting as these numbers are, we expect them to grow, with the library itself anticipated to exceed one billion lead-like molecules by 2020. This represents a great challenge but also a great opportunity: a 1,000-fold expansion of the molecules and chemotypes readily available to chemical biology and to drug discovery that is openly accessible to the community (http://zinc15.docking.org).
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-0917-9. 
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Database generation. Dockable ligand databases can be downloaded from ZINC (http://zinc15.docking.org) and protonation states and tautomers (Jchem v.15.11.23.0, https://chemaxon.com/), three-dimensional structures (Corina v.3.6.0026, https://www.mn-am.com/products/corina), conformational ensembles (omega v.2.5.1.4, https://www.eyesopen.com/omega) 50 , atomic charges 51 and desolvation energies 52,53 are calculated as previously described 54 . For both the AmpC and D 4 receptor campaigns, library molecules were protonated according to experimental testing near neutral pH, using logarithmic acid dissociation constant (pK a ) values calculated according to Jchem. Whereas AmpC is known to prefer anionic molecules, and dopamine receptors are known to prefer cations, there is a precedent for uncharged molecules that bind to both 55, 56 . Accordingly, the full library, unfiltered for charge state except by lead-like characteristics, was docked against both targets. The full list of docked library molecules, by ZINC number, SMILES and docking scores, has been deposited in FigShare (https://doi.org/10.6084/ m9.figshare.7359626.v2 and https://doi.org/10.6084/m9.figshare.7359401.v3); from this, full charge and structural representations can be found at http://zinc15. docking.org. Toy model for database growth. We constructed a model of ligand enrichment with library size, using the distribution of ligand and decoy docking scores. Except for the D 4 receptor, the ligands and decoys are drawn from the DUD-E benchmark; for the D 4 receptor, 48 ligands were downloaded from IUPHAR (http://www. guidetopharmacology.org) and the corresponding decoys were generated by the DUD-E web server (http://dude.docking.org/generate). Inputs to the model are the ligand-to-decoy ratio and the number of molecules in databases. From these two parameters, the distributions are sampled. We generated distributions by fitting the skewed-normal distribution to that observed for the DUD-E ligands and decoys from docking, using the statistical library in SciPy (Extended Data Fig. 1a-c and Supplementary Table 1 ). Simulating hit rates from full-library docking. We docked the full make-ondemand library to investigate the ranking of ligands versus decoys. All known ligands for each target were drawn from ChEMBL 26 . Their analogues in the makeon-demand library were defined by ECFP4 Tc similarity ≥0.5, ≥0.6 or ≥0.7 for each target (Extended Data Fig. 1d ). Together, the known active compounds and their analogues were defined as ligands, and the rest of the docked molecules were defined as decoys. The full library was then docked. To investigate the effect of library size on the ability to enrich ligands among the top 1,000 ranked compounds, 10 5 , 3 × 10 5 , 10 6 , 3 × 10 6 , 10 7 , 3 × 10 7 and 10 8 sets of molecules were randomly selected from the full docking-ranked list and the number of ligands among the 1,000 was counted. Each set was pulled twenty times with random selection from the larger library. Bemis-Murcko scaffold analysis. The SMILES of all the make-on-demand lead-like molecules in ZINC were downloaded from http://zinc15.docking.org/ tranches/home/ on 28 February 2018. The program mitools (https://www.molinspiration.com/) calculated scaffolds for all 233 million lead-like molecules using the Bemis and Murcko method 25 . Large-scale docking. The AmpC campaign used the structure in PDB 1L2S, whereas the D 4 receptor campaign used PDB 5WIU. In each, 45 matching spheres were calculated around and including the ligand atoms-a 26 μM thiophene carboxylate for AmpC and nemonapride for D 4 -and structures were prepared and AMBER united atom charges assigned 14 . The magnitude of the partial atomic charges for five residues in AmpC was increased without changing the net residue charge 55 . For both targets, the low protein dielectric was extended into the binding site using pseudo-atom positions that represented possible ligand docking sites; the radius was 1.0 Å and 2.0 Å for D 4 and AmpC, respectively 14, 53, 57 . For the D 4 receptor, the desolvation volume of the site was also increased by similar atom positions, using a radius of 0.3 Å. This improved the ligand charge balance in benchmarking calculations, reducing the number of high-ranking dications. Energy grids representing the AMBER van der Waals potential 58 , Poisson-Boltzmann electrostatic potentials using QNIFFT 59, 60 and ligand desolvation from the occluded volume of the target for different ligand orientations 53 were calculated. Using DOCK3.7.2 61 , over 99 million and over 138 million library molecules were docked against AmpC and the D 4 receptor, respectively. Each library molecule was sampled in about 4,054 and 3,300 orientations and, on average, 280 and 479 conformations for AmpC and D 4 , respectively, and were rigid-body-minimized with a simplex minimizer. The throughput averaged 1 s per library compound. Clustering. To increase novelty, the high-ranking molecules from both screens were filtered for similarity to previously known ligands and for similarity to the molecules in the 3.5-million in-stock library (we have deposited tools to do this at https://github.com/docking-org/ChemInfTools). To increase diversity, the docking-ranked molecules were clustered into related families of compounds. For the AmpC screen, the top 1 million ranked molecules were best-first clustered using an ChemAxon ECFP4 Tc of 0.5 for cluster inclusion (using the Tc_c_tool that we have deposited at https://github.com/docking-org/ChemInfTools). For the D 4 screen, we wanted to sample through the docking scoring range, and thus used a hybrid clustering approach to treat many more molecules. To cluster the 53,588,665 molecules with DOCK scores better than −30 kcal mol −1 against the D 4 receptor, we used best-first clustering on the first 2 million molecules (DOCK score to −49.38 kcal mol −1 ). This resulted in 126,287 clusters. Bemis-Murcko scaffolds were calculated for the full 53,588,665 molecules, resulting in 4,893,388 scaffold-based clusters. The ECFP4-based clusters and the scaffold-based clusters were combined, and ECFP4 best-score first clustering was run on the best scoring members of each cluster, again using a 0.5 Tc cut-off. This left 423,656 hybrid clusters, each represented by its top-scoring member. Analysis of full library docking versus pre-clustering library docking. The scaffold analysis of all docked molecules against AmpC and D 4 receptor used Bemis-Murcko scaffolds, as above. For the full library docking, the best-scoring member was selected to represent the scaffold. To investigate the influence of only docking cluster representatives, rather than docking the full library, scaffold representatives were picked by four different methods: (1) the closest member to the centroid by molecular mass and a calculated log octanol/water value of the partition coefficient of the compound (clogP), (2) the closest member to the centroid of molecular mass alone, (3) the member with the largest molecular mass and (4) the member with the smallest molecular mass. The molecular mass values are calculated and the clogP values are predicted by Rdkit (http://www.rdkit.org). Analoging within the library. The 90 AmpC analogues from within the make-ondemand library were selected on the basis of topological similarity to the primary docking hits: each had an ECFP4-based Tc ≥ 0.5 or shared the same substructure as the initial hit. All prioritized analogues also had favourable docking scores to the enzyme. Make-on-demand synthesis. Compounds were synthesized using 70,000 qualified in-stock building blocks and 130 well-characterized, two-component reactions at Enamine. Historically, molecules have been synthesized in three to four weeks with an 85% fulfilment rate; in this project delivery time was six weeks, but with a 93% fulfilment rate. Each reaction is well-tested for conditions, including temperatures, completion time and mixing, as previously described 62 . Typically, compounds are made in parallel by combining reagents and solvents in a single vial in the appropriate conditions to allow the reaction to proceed to completion. The product-containing vial is filtered by centrifugation into a second vial to remove precipitate and the solvent is evaporated under reduced pressure; the product is then purified by high-performance liquid chromatography. Identity and purity is assessed by liquid chromatography-mass spectrometry, 1 H and 13 C NMR. All compounds were shipped with 90% (most with 95%) or higher purity ( Supplementary  Tables 9, 10 and Supplementary Data 11-14) . AmpC crystallography. All four inhibitors, 547933290, 275579920, 339204163 and 549719643, were cocrystalized from 1.7 M potassium phosphate with microseeding at pH values that varied from 8.7 to 8.9, as previously described 63 . Crystals were cryo-cooled in a solution that contained a reservoir solution and 25% sucrose. Reflections were measured at beamline 8.3.1 of the Advanced Light Source with a wavelength of 1.11583 nm at a temperature of 100 K. Complexes with 547933290, 275579920, 339204163 and 549719643 were measured to a resolution of 1.50 Å, 1.91 Å, 1.90 Å and 1.79 Å, respectively (Extended Data Table 1 ). All four complexes crystalized in the C2 space group with two molecules in the asymmetric unit 63 . The datasets were processed, scaled and merged using XDS and AIMLESS 64 . MOLREP was used for molecular replacement using the protein model from PDB 1KE4, giving unbiased electron densities for the inhibitor in initial electron density maps. Initial model fitting and water addition was done in COOT 65 followed by refinement in REFMAC 66 . Geometry restraints of inhibitor molecules were created in eLBOW-PHENIX. Following inhibitor modelling in COOT, refinement was carried out using PHENIX 67 . For each structure, geometry was assessed using MolProbity. The final models of 547933290, 275579920, 339204163 and 549719643 in complex with AmpC were refined to R work and R free values of 19.1 and 22.3%, 19.4 and 23.2%, 17.1 and 20.3%, and 18.6 and 22%, respectively. Coordinates have been deposited with PDB identifiers 6DPZ, 6DPY, 6DPX and 6DPT, respectively. Model quality was confirmed using PROCHECK. The total number of residues located in the most favourable and allowed region of the Ramachandran plot for the complexes with 547933290, 275579920, 339204163 and 549719643 were 97.89% and 2.11%, 98.03% and 1.97%, 98.31% and 1.69%, and 98.03% and 1.97%, respectively. The data measurement and refinement statistics are summarized in Extended Data Table 1 . AmpC enzymology. All candidate inhibitors were dissolved in DMSO at 30 mM, and more dilute DMSO stocks were prepared as necessary so that the concentration of DMSO was held constant at 1% v/v in 50 mM sodium cacodylate buffer, pH 6.5. AmpC activity and inhibition was monitored spectrophotometrically using either CENTA or nitrocephin as substrates 68 . All assays included 0.01% Triton X-100 to reduce compound aggregation artefacts 69 . Active compounds were further investigated for aggregation by dynamic light scattering and by inhibition of three counter-screening enzymes: trypsin, chymotrypsin and malate dehydrogenase 36 .
Unless otherwise stated, no active compound was found to form aggregates nor did they inhibit any of the three counter-screening enzymes ( Supplementary Tables 2,  3 ). IC 50 values reflect the percentage inhibition fit to a dose-response equation in GraphPad Prism (GraphPad), whereas K i values were calculated directly from Lineweaver-Burk plots for all compounds, except for ZINC170811339, ZINC184991516, ZINC171610178 and 547933290, for which the Cheng-Prusoff equation was used. D 4 receptor radioligand binding assay. Binding was measured using membrane preparations from HEK293T cells that transiently expressed human D 2 (D 2 long receptor), D 3 and D 4 (D 4.4 variant). HEK293T cells (ATCC CRL-11268; 59587035; mycoplasma free) were transfected and membrane preparation and radioligand binding assays were set up in 96-well plates in the standard binding buffer (50 mM Tris, 10 mM MgCl 2 , 0.1 mM EDTA, 0.1% BSA, pH 7.4) 14 . For primary screening, 10 μM compounds were incubated with membrane and radioligands (0.8-1.0 nM 3 H-N-methylspiperone) (PerkinElmer). For displacement experiments, test compounds with increasing concentrations were incubated with the membrane and radioligands (0.8-1.0 nM 3 H-N-methylspiperone). Reactions for either primary screening or displacement experiments were incubated for 2 h at room temperature in the dark and terminated by rapid vacuum filtration onto chilled 0.3% PEI-soaked GF/A filters, followed by three quick washes with cold washing buffer (50 mM Tris HCl, pH 7.4) and quantified as previously described 70 . Results (with or without normalization) were analysed using GraphPad Prism 5.0 using one-site shift models where indicated. cAMP inhibition assay. To measure D 4 Gα i/o -mediated cAMP inhibition, HEK293T (ATCC CRL-11268; 59587035; mycoplasma free) cells were cotransfected with human D 4 (D 4.4 variant) along with a luciferase-based cAMP biosensor (GloSensor; Promega) and assays were performed as previously described 14 . After 16 h, transfected cells were seeded in poly-l-lysine-coated 384-well white clear-bottom cell culture plates (Greiner; 10,000 cells per well, 40 μl per well) in DMEM containing 1% dialysed FBS. The next day, ligand solutions were prepared in fresh buffer (20 mM HEPES, 1× HBSS, 0.3% bovine serum album (BSA), pH 7.4) at 3× the drug concentration. Plates were decanted and received 20 μl per well of ligand buffer followed by addition of 10 μl of ligand solution (3 wells per condition) for 15 min in the dark at room temperature. To measure agonist activity for Gα i/o -coupled receptors, 10 μl luciferin (4 mM final concentration) supplemented with isoproterenol (400 nM final concentration was added to activate G s via endogenous β 2 -adrenergic receptors) and luminescence intensity was quantified 10 min later. Data were analysed using 'log(agonist) versus response' in GraphPad Prism 5.0. Bioluminescence resonance energy transfer (BRET) assay. To measure D 4mediated G protein activation, HEK293T cells were co-transfected with human D 4 , Gα i 1 containing C-terminal Renilla luciferase (RLuc8), Gβ and Gγ containing a C-terminal GFP (at mass ratio 1:0.3:2:2, respectively). To measure D 4 -mediated arrestin recruitment, HEK293T cells were co-transfected with human D 4 containing C-terminal RLuc8 and β-arrestin-2 containing a N-terminal YFP at ratio 1:3. After at least 16 h, transfected cells were plated in poly-l-lysine-coated 96-well white clear-bottom cell culture plates in plating medium (DMEM and 1% dialysed FBS) at a density of 40,000-50,000 cells in 200 μl per well and incubated overnight. The next day, the medium was decanted and cells were washed twice with 60 μl of drug buffer (20 mM HEPES, 1× HBSS, pH 7.4), then 60 μl of the RLuc substrate, coelenterazine 400a for G protein assay, and coelenterazine h for β-arrestin-2 assay (Promega, 5 μM final concentration in drug buffer), was added per well, incubated an additional 5 min to allow for substrate diffusion. Afterwards, 30 μl of drug (3×) in drug buffer (20 mM HEPES, 1× HBSS, 0.1% BSA, pH 7.4) was added per well and incubated for another 5 min. Plates were immediately read for luminescence at 400 nm and GFP fluorescence emission at 515 nm (G protein assay); 485 nm and eYFP fluorescence emission at 530 nm (β-arrestin-2 assay) for 1 s per well using a Mithras LB940 multimode microplate reader. The ratio of GFP/RLuc or eYFP/ RLuc was calculated per well and the net BRET ratio was calculated by subtracting the GFP/RLuc or eYFP/RLuc from the same ratio in wells without GFP or eYFP present. The net BRET ratio was plotted as a function of drug concentration using Graphpad Prism 5 (Graphpad). Hit-rate curve prediction and estimation of maximum number of hits. To define the docking scoring ranges from which molecules would be picked for experimental testing, we used distributions of prior probabilities from Bayesian statistics for highest, mid-point and random hit rates, and for the slope of the curve. To advance the argument, we assumed that docking hit rates would behave in a manner similar to a dose-response curve as a function of docking energy, e i : This function is defined by four parameters: (1) top is the maximum hit rate;
(2) dock 50 is the dock energy in kcal mol −1 at top/2; (3) S = slope × 4/top, in which slope is the change in the hit rate at dock 50 in hit rate %/(kcal mol −1 ); and (4) bottom is the minimum hit rate that we fixed at zero. To define the prior probability distribution, 4 authors graded 440 compounds across 11 energy slices (Extended Data Fig. 8e ), from which we chose independent Bayesian prior probabilities for each parameter, α β = = = P(top) beta ( 20, 80) ,
= . normal( 0 2, 01) (Extended Data Fig. 8b-d) . To sample curves from the posterior distribution given the prior distribution and given the results of testing the 549 compounds, we used Hamiltonian Monte Carlo with no-u-turn sampling with Stan 71 (four chains of 50,000 warm-up and 50,000 sampling steps each and adapt_delta = 0.99 and max_treedepth = 12 control parameters) ( Fig. 4a and Extended Data Fig. 8b-d) . To select the most informative compounds to test, we evaluated the Shannon information gain of six candidate designs, defined as the expected difference in posterior minus prior entropy over the prior-predictive distribution, by nested Monte Carlo 72, 73 . We selected design 5 favouring higher information gain over number of active compounds (Extended Data Fig. 8f ). To estimate the number of active compounds (Fig. 4b ) and scaffolds (Extended Data Fig. 8g ), the energies of the compounds and scaffold cluster heads were integrated over the uncertainty in the posterior hit-rate model (Extended Data Fig. 8h, i 
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